Related Experiment Video

Updated: Aug 19, 2026

Hepatocyte-specific Ablation in Zebrafish to Study Biliary-driven Liver Regeneration
08:14

Hepatocyte-specific Ablation in Zebrafish to Study Biliary-driven Liver Regeneration

Published on: May 20, 2015

Novel role for amphiregulin in protection from liver injury

Carmen Berasain1, Elena R García-Trevijano, Josefa Castillo

  • 1Division of Hepatology and Gene Therapy, Centro de Investigación Médica Aplicada, Facultad de Medicina, Universidad de Navarra, Pío XII, 55, 31008 Pamplona, Spain.

The Journal of Biological Chemistry
|March 9, 2005
PubMed

Insights

Amphiregulin protects liver cells from Fas-mediated apoptosis, a key factor in liver disease. This finding suggests amphiregulin as a potential therapeutic for liver conditions.

Area of Science:

  • Hepatology
  • Immunology
  • Molecular Biology

Background:

  • The Fas/Fas ligand system is crucial in hepatocyte apoptosis, contributing to liver disease.
  • Inhibiting hepatocyte apoptosis is a therapeutic target for liver diseases.
  • Epidermal growth factor receptor (EGFR) activation promotes hepatocyte survival.

Purpose of the Study:

  • To investigate the expression of EGFR ligands during Fas-mediated liver injury.
  • To determine the role of amphiregulin in Fas-induced liver damage and apoptosis.
  • To explore amphiregulin's therapeutic potential in liver diseases.

Main Methods:

  • Mice were challenged with a Fas-agonist antibody to induce liver injury.
  • Expression of EGFR ligands (EGF, TGF-α, HB-EGF, betacellulin, epiregulin, amphiregulin) was analyzed in the liver.
  • Amphiregulin was administered to mice, and its effects on Fas-mediated injury and primary hepatocytes were assessed.
  • Amphiregulin knockout mice were used to study its role in liver damage and survival.

Main Results:

  • Amphiregulin expression was significantly upregulated in response to Fas-mediated liver injury.
  • Amphiregulin administration protected mice from Fas-mediated liver injury and showed direct anti-apoptotic effects on hepatocytes.
  • Amphiregulin activated Akt and STAT3 survival pathways and increased Bcl-xL expression.
  • Amphiregulin knockout mice exhibited chronic liver damage and increased susceptibility to lethal Fas-induced injury.

Conclusions:

  • Amphiregulin is an endogenous protective factor induced by liver damage.
  • Amphiregulin demonstrates therapeutic potential for treating liver diseases by inhibiting apoptosis.
  • The study highlights amphiregulin's critical role in maintaining liver homeostasis and preventing injury.

More Related Videos

Partial Lobular Hepatectomy: A Surgical Model for Morphologic Liver Regeneration05:37

Partial Lobular Hepatectomy: A Surgical Model for Morphologic Liver Regeneration

Published on: May 31, 2018

Related Concept Videos

Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...